FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to a means correcting cholinergic disorders of mnestic processes. Use of diterpene alkaloid songorine as a means of correcting the cholinergic disorders of mnestic processes.
EFFECT: above-described agent is effective for correcting cholinergic disorders of mnestic processes.
1 cl, 1 dwg, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT POSSESSING ANXIOLYTIC ACTIVITY | 2015 |
|
RU2571286C1 |
| AGENT FOR CORRECTION OF MNESTIC DISORDERS | 2023 |
|
RU2834960C2 |
| ACTIVE INGREDIENT OF MEDICINAL AGENT WITH CEREBROPROTECTIVE, ANTIHYPOXIC AND ANTIAMNESTIC ACTIVITY FOR TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND METHOD FOR PREPARING THE SAME | 2023 |
|
RU2821508C1 |
| METHOD FOR TREATING AFFECTED AMNESTIC FUNCTIONS | 2004 |
|
RU2268726C2 |
| AGENT SHOWING PROPERTIES OF COGNITIVE FUNCTION ACTIVATOR (VERSIONS) | 2010 |
|
RU2438672C1 |
| CEREBROPROTECTIVE AGENT | 2012 |
|
RU2501562C1 |
| QUINAZOLINE DERIVATIVES, POSSESSING NOOTROPIC AND ANTIHYPOXIC ACTIVITY | 2012 |
|
RU2507198C1 |
| METHOD OF SYNTHESIS OF (3aR,4S,8S,12R,12aS,12bR)-10-METHYL-2-PHENYLOCTAHYDRO-1H-4,12a-ETHENO-8,12-METHANOPYRROLO[3',4':3,4]PYRIDO[1,2-a][1,5]DIAZOCINE-1,3,5(4H)-TRIONE WITH NOOTROPIC, HYPOGLYCEMIC, ANTIHYPOXIC AND ANTIAGGREGATORY PROPERTIES | 2024 |
|
RU2836645C1 |
| PHARMACEUTICALLY ACCEPTABLE ACETYL-(D-LYS)-LYS-ARG-ARG-AMIDE PEPTIDE SALTS | 2021 |
|
RU2763136C1 |
| NEUROTROPIC AGENT WITH ANTIOXIDANT, ANTIHYPOXIC, NEUROPROTECTOR, ANTIAMNESIC AND ANTI-MOTION SICKNESS ACTIVITY AND CAPABLE OF ENHANCING COGNITIVE FUNCTIONS | 2008 |
|
RU2394816C1 |
